(Borderline Amniotic Fluid Index and Perinatal Outcome (Controlled Clinical Trial

Abstract

Antenatal tests are done during the course of pregnancy to evaluate fetus health and the risk of adverse outcomes. Amniotic fluid is an important part of pregnancy which plays vital role in the normal growth of the fetus and promotes muscular skeletal development and allows for easier fetal movement. Amniotic fluid assessment is an essential part of evaluation of fetus health, fetal distress, meconium aspiration and fetal mortality. Normal amniotic fluid predicts normal placental function, fetal growth and fetal well-being. Decreased amniotic fluid is often associated with chronic uteroplacental insufficiency, maternal vascular diseases and fetal oliguria. In some patients, oligohydramnios is idiopathic in the third trimester. The assessment of amniotic fluid volume is very crucial for survival of the fetus and the Amniotic Fluid Index (AFI) is the most common way for the estimation of amniotic fluid volume which is performed by ultrasound. Different accepted methods of diagnosis exis. Borderline amniotic fluid index has been defined as an amniotic fluid index (AFI) of 5–8cm, which is measured using the four-quadrant technique.